Oxford Biomedica Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	96.88	60.65	103.72	141.29	108.94
Trading Asset Securities	-	-	-	-	0.07
Cash & Short-Term Investments	96.88	60.65	103.72	141.29	109.02
Cash Growth	59.74%	-41.52%	-26.59%	29.60%	132.04%
Accounts Receivable	71.27	41.33	13.34	45.01	35.95
Other Receivables	-	13.7	7.04	12.61	6.15
Receivables	71.27	55.03	20.39	57.62	42.1
Inventory	17.33	13.57	12.87	12.63	9.52
Prepaid Expenses	-	3.94	4.36	3.98	3.21
Other Current Assets	0.17	-	-	-	-
Total Current Assets	185.65	133.19	141.33	215.5	163.84
Property, Plant & Equipment	107.63	64.3	75.69	133.78	69.73
Goodwill	-	-	-	0.66	-
Other Intangible Assets	25.17	29.22	30.98	105.23	0.05
Long-Term Accounts Receivable	7.28	0.03	0.04	-	-
Other Long-Term Assets	-	4.9	4.3	5.01	3.61
Total Assets	325.72	231.64	252.34	460.18	237.23
Accounts Payable	35.36	9.61	6.05	13.6	5.26
Accrued Expenses	-	15.04	10.27	20.63	11.9
Current Portion of Long-Term Debt	-	0.28	-	-	-
Current Portion of Leases	6.06	4.14	3.65	3.3	0.85
Current Income Taxes Payable	-	1.51	1.48	2.35	1.9
Current Unearned Revenue	42.8	24.19	22.11	19.26	13.4
Other Current Liabilities	-	3.54	0.75	-	-
Total Current Liabilities	84.22	58.32	44.32	59.66	33.31
Long-Term Debt	41.49	39.79	38.53	39.78	-
Long-Term Leases	100.58	64.55	69.27	71.21	8.49
Long-Term Unearned Revenue	0.69	1.07	5.33	1.15	1.85
Long-Term Deferred Tax Liabilities	-	-	-	5.59	-
Other Long-Term Liabilities	7.39	7.42	17.06	46.61	6.24
Total Liabilities	234.37	171.16	174.51	223.99	49.89
Common Stock	60.38	52.98	48.4	48.13	43.09
Additional Paid-In Capital	445.85	394.86	380.33	379.95	307.77
Retained Earnings	-422.35	-399.5	-352.92	-198.55	-165.81
Comprehensive Income & Other	7.47	8.71	-1.81	-24.89	2.29
Total Common Equity	91.35	57.05	74.01	204.65	187.34
Minority Interest	-	3.44	3.83	31.54	-
Shareholders' Equity	91.35	60.49	77.83	236.19	187.34
Total Liabilities & Equity	325.72	231.64	252.34	460.18	237.23
Total Debt	148.13	108.76	111.46	114.28	9.34
Net Cash (Debt)	-51.24	-48.11	-7.74	27	99.68
Net Cash Growth	-	-	-	-72.91%	200.80%
Net Cash Per Share	-0.46	-0.47	-0.08	0.28	1.16
Filing Date Shares Outstanding	117.81	105.96	96.8	96.26	86.18
Total Common Shares Outstanding	117.81	105.96	96.8	96.26	86.18
Working Capital	101.43	74.87	97.01	155.84	130.54
Book Value Per Share	0.78	0.54	0.76	2.13	2.17
Tangible Book Value	66.18	27.83	43.03	98.77	187.29
Tangible Book Value Per Share	0.56	0.26	0.44	1.03	2.17
Machinery	-	70.8	65.33	61.02	40.17
Leasehold Improvements	-	61.29	61.06	60.23	28.15
Order Backlog	-	150	94	94	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.